Showing results (21-30 of 29) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Molecular Cancer Therapeutics|July 11, 2007
The HLA A*0201-restricted hTERT(540-548) peptide is not detected on tumor cells by a CTL clone or a high-affinity T-cell receptorMarco A Purbhoo, Yi Li, Deborah H Sutton, et al.The Journal of Experimental Medicine|April 20, 2005
Structural and kinetic basis for heightened immunogenicity of T cell vaccinesJi-Li Chen, Guillaume Stewart-Jones, Giovanna Bossi, et al.The Journal of Experimental Medicine|May 9, 2007
The length of lipids bound to human CD1d molecules modulates the affinity of NKT cell TCR and the threshold of NKT cell activationCorinna McCarthy, Dawn Shepherd, Sebastian Fleire, et al.Biorxiv : the Preprint Server for Biology|November 24, 2025
Inhibition of cell-mediated immunity in type 1 diabetes by beta cell-targeted PD-1 agonists in pancreas tissue slicesMatthew W Becker, Matthew Brown, Katherine Wiseman, et al.Science Advances|April 1, 2026
Beta cell-targeted PD-1 agonist inhibits cell-mediated autoimmunity in pancreas tissue slicesMatthew W Becker, Matthew E Brown, Katherine Wiseman, et al.JCI Insight|September 7, 2021
Cell-targeted PD-1 agonists that mimic PD-L1 are potent T cell inhibitorsAdam P Curnock, Giovanna Bossi, Jyothi Kumaran, et al.Plos One|October 16, 2018
An approved in vitro approach to preclinical safety and efficacy evaluation of engineered T cell receptor anti-CD3 bispecific (ImmTAC) moleculesJane Harper, Katherine J Adams, Giovanna Bossi, et al.Science Translational Medicine|August 9, 2013
Identification of a Titin-derived HLA-A1-presented peptide as a cross-reactive target for engineered MAGE A3-directed T cellsBrian J Cameron, Andrew B Gerry, Joseph Dukes, et al.Nature Medicine|May 8, 2012
Monoclonal TCR-redirected tumor cell killingNathaniel Liddy, Giovanna Bossi, Katherine J Adams, et al.Pageof 3